New advances in the treatment of generalized lipodystrophy: role of metreleptin
Alexander J Rodriguez,1 Claudio A Mastronardi,2 Gilberto J Paz-Filho2 1Department of Medicine, Monash Medical Centre, Clayton, VIC, 2Department of Genome Sciences, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, AustraliaAbstract: Recombinant m...
Saved in:
Main Authors: | Rodriguez AJ (Author), Mastronardi CA (Author), Paz-Filho GJ (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metreleptin for the treatment of progressive encephalopathy with/without lipodystrophy (PELD) in a child with progressive myoclonic epilepsy: a case report
by: Stefania Pedicelli, et al.
Published: (2020) -
Metreleptin Treatment in a Boy with Congenital Generalized Lipodystrophy due to Homozygous c.465_468delGACT (p.T156Rfs*8) Mutation in the BSCL2 Gene: Results From the First-year
by: Şervan Özalkak, et al.
Published: (2023) -
Lipodistrofia generalizada congênita Congenital generalized lipodystrophy
by: Paulo P. Figueiredo Filho, et al.
Published: (2004) -
Congenital Generalized Lipodystrophy: A Multisystemic Metabolic Disorder
by: Vishal V Tewari, et al.
Published: (2016) -
Causes of lipodystrophy
by: Katarzyna Korabiusz, et al.
Published: (2018)